BET1L and amyotrophic lateral sclerosis: Additional post-hoc comparisons revealed that ALS rats showed a lower level of innervated NMJs at both Week 1 and Week 3 (P < 0.05, Figure 4C), indicating that more severe effects in NMJ integrity were induced by siRNA-based Bet1L in ALS model rats.